Patent ID: 11918693
Assignee: HALEON US HOLDINGS LLC
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 2:
3. The oral tablet according to claim 1 comprising:
(i) the active ingredients present intragranularly;
(ii) 8% to 15% by weight pregelatinized starch, present intragranularly;
(iii) 1% to 2% by weight Hypromellose, present intragranularly;
(iv) 1% to 2% by weight of glyceryl dibehenate, present extragranularly;
(v) 5% to 8% by weight croscarmellose, present intragranularly and extragranularly; and
(vi) 2% to 4% by weight colloidal silicon dioxide, present intragranularly and extragranularly.